Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impact of Red Cell Distribution Width on Dysplasia and Clinical Outcome in 66 Patients with Myelodysplastic Syndrome without Increased Blasts

Yuta Baba, PhD MD, Bungo Saito, MD PhD, Shotaro Shimada, MD, Yohei Sasaki, MD, So Murai, MD, Maasa Abe, MD, Shun Fujiwara, MD, Nana Arai, MD, Yukiko Kawaguchi, MD, Nobuyuki Kabasawa, MD, Hiroyuki Tsukamoto, MD PhD, Yui Uto, MD PhD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD PhD

Blood (2018) 132 (Supplement 1): 5522.

https://doi.org/10.1182/blood-2018-99-113973

Published: 2018

Journal Articles

Increased C-Reactive Protein Level Is Associated with Poor Prognosis in Patients with Follicular Lymphoma Treated with Rituximab-Containing Regimens

Yukiko Kawaguchi, MD, Bungo Saito, MD PhD, Yohei Sasaki, MD, Shotaro Shimada, MD, Megumi Watanuki, MD, Maasa Abe, MD, So Murai, MD, Yuta Baba, MD, Shun Fujiwara, MD, Nana Arai, MD, Nobuyuki Kabasawa, MD, Hiroyuki Tsukamoto, MDPhD, Yui Uto, MD PhD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Eisuke Shiozawa, MD PhD, Masafumi Takimoto, MD PhD, Tsuyoshi Nakamaki, MD PhD

Blood (2017) 130 (Supplement 1): 4067.

https://doi.org/10.1182/blood.V130.Suppl_1.4067.4067

Published: 2017

Journal Articles

High-Dose Ara-C, Carboplatin, Etoposide, and Steroids (ACES) Is Effective in Relapse and Refractory Non-Hodgkin Lymphoma

Nobuyuki Kabasawa, MD, Bungo Saito, MD PhD, Yohei Sasaki, MD, Shotaro Shimada, MD, Maasa Abe, MD, So Murai, MD, Yuta Baba, MD, Megumi Watanuki, MD, Yukiko Kawaguchi, MD, Nana Arai, MD, Shun Fujiwara, MD, Hiroyuki Tsukamoto, MDPhD, Yui Uto, MD PhD, Hirotsugu Ariizumi, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD PhD

Blood (2017) 130 (Supplement 1): 2850.

https://doi.org/10.1182/blood.V130.Suppl_1.2850.2850

Published: 2017

Journal Articles

Soluble Interleukin-2 Receptor and C-Reactive Protein Levels Are Associated with the Efficacy of Bendamustine As a Salvage Treatment for Indolent Lymphoma

Yukiko Kawaguchi, MD, Bungo Saito, MD, Maasa Abe, MD, Yuta Baba, MD, Sou Murai, MD, Megumi Watanuki, MD, Nana Arai, MD, Shun Fujiwara, MD, Nobuyuki Kabasawa, MD, Hiroyuki Tsukamoto, MD, Yui Uto, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Tsuyoshi Nakamaki, MD

Blood (2016) 128 (22): 1797.

https://doi.org/10.1182/blood.V128.22.1797.1797

Published: 2016

Journal Articles

Detection of Microbial Substitution in the Oral Cavity of Patients Undergoing Hematopoietic Stem Cell Transplantation with Vitek MS TM , a MALDI-TOF Mass Spectrometry System

Luna Osakabe, DDS, Bungo Saito, MD, Nana Arai, MD, Yukiko Kawaguchi, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Akemi Utsumi, DDS, Kunihiko Fukuchi, MD, Tsuyoshi Nakamaki, MD, Shouji Hironaka, DDS

Blood (2016) 128 (22): 5752.

https://doi.org/10.1182/blood.V128.22.5752.5752

Published: 2016

Journal Articles

Rituximab-Induced CD20-Mediated Signals and Suppression of PI3K-AKT Pathway Cooperates to Inhibit B-Cell Lymphoma Growth By Down-Regulation of Myc.

Tsuyoshi Nakamaki, MD, Yuta Baba, MD, Maasa Abe, MD, Sou Murai, MD, Megumi Watanuki, MD, Nobuyuki Kabasawa, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Yukiko Kawaguchi, MD, Nana Arai, MD, Shun Fujiwara, MD, Bungo Saito, MD

Blood (2016) 128 (22): 5312.

https://doi.org/10.1182/blood.V128.22.5312.5312

Published: 2016

Journal Articles

Immunohistochemical Expression of CD123 Is Associated with an Inferior Clinical Outcome in Acute Myeloid Leukemia

Nana Arai, MD, Bungo Saito, MD, Maasa Abe, MD, Megumi Watanuki, MD, So Murai, MD, Yuta Baba, MD, Yukiko Kawaguchi, MD, Shun Fujiwara, MD, Hiroyuki Tsukamoto, MD, Yui Uto, MD, Nobuyuki Kabasawa, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Mayumi Homma, MD, Eisuke Shiozawa, MD, Toshiko Yamochi, MD, Masafumi Takimoto, MD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD

Blood (2016) 128 (22): 2887.

https://doi.org/10.1182/blood.V128.22.2887.2887

Published: 2016

Journal Articles

Scoring System Using Age, C-Reactive Protein, Hemoglobin, and Albumin (ACHA) For Predicting Outcomes Of Diffuse Large B-Cell Lymphoma In The Rituximab-Era

Hirotsugu Ariizumi, MD, Bungo Saito, MD, Eisuke Shiozawa, MD, Yui Uto, MD, Norimichi Hattori, MD, Kouji Yanagisawa, MD, Hidetoshi Nakashima, MD, Hiroshi Harada, MD, Hiraku Mori, MD, Tsuyoshi Nakamaki, MD

Blood (2013) 122 (21): 4305.

https://doi.org/10.1182/blood.V122.21.4305.4305

Published: 2013

Journal Articles

Analysis of CD20-Mediated Signals in Refractory Diffuse Large B-Cell Lymphoma Cells.

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, Hidetoshi Nakashima, MD, Hirotsugu Ariizumi, MD, Takashi Maeda, MD, Bungo Saito, MD, Kouji Yanagisawa, MD, Shigeru Tomoyasu, MD

Blood (2012) 120 (21): 2684.

https://doi.org/10.1182/blood.V120.21.2684.2684

Published: 2012

Journal Articles

Inhibition of Phosphatidylinositol 3-Kinase Is Effective to Suppress the Growth of CD20-Negative Refractory Diffuse Large B-Cell Lymphoma Cells

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, MD, Hidetoshi Nakashima, MD, Hirotsugu Ariizumi, MD, Takashi Maeda, MD, Bungo Saito, MD, Kouji Yanagisawa, MD, Shigeru Tomoyasu, MD, Eisuke Shiozawa, MD, Toshiko Yamochi-Onizuka, MD, Hidekazu Ota, MD

Blood (2011) 118 (21): 2421.

https://doi.org/10.1182/blood.V118.21.2421.2421

Published: 2011

Journal Articles

Constitutive Cyclin A1 Expression Induces Abrogation of Cell Cycle Check Points Associated with Ara-C Resistance in Myeloid Leukemia Cells.

Tsuyoshi Nakamaki, Kunihiko Fukuchi, Norimichi Hattori, Hidetoshi Nakashima, Takashi Maeda, Kouji Yanagisawa, Bungo Saito, Isao Matsuda, Shigeru Tomoyasu

Blood (2009) 114 (22): 4801.

https://doi.org/10.1182/blood.V114.22.4801.4801

Published: 2009

NARROW

Impact of Red Cell Distribution Width on Dysplasia and Clinical Outcome in 66 Patients with Myelodysplastic Syndrome without Increased Blasts

Increased C-Reactive Protein Level Is Associated with Poor Prognosis in Patients with Follicular Lymphoma Treated with Rituximab-Containing Regimens

High-Dose Ara-C, Carboplatin, Etoposide, and Steroids (ACES) Is Effective in Relapse and Refractory Non-Hodgkin Lymphoma

Soluble Interleukin-2 Receptor and C-Reactive Protein Levels Are Associated with the Efficacy of Bendamustine As a Salvage Treatment for Indolent Lymphoma

Detection of Microbial Substitution in the Oral Cavity of Patients Undergoing Hematopoietic Stem Cell Transplantation with Vitek MS TM , a MALDI-TOF Mass Spectrometry System

Rituximab-Induced CD20-Mediated Signals and Suppression of PI3K-AKT Pathway Cooperates to Inhibit B-Cell Lymphoma Growth By Down-Regulation of Myc.

Immunohistochemical Expression of CD123 Is Associated with an Inferior Clinical Outcome in Acute Myeloid Leukemia

Scoring System Using Age, C-Reactive Protein, Hemoglobin, and Albumin (ACHA) For Predicting Outcomes Of Diffuse Large B-Cell Lymphoma In The Rituximab-Era

Analysis of CD20-Mediated Signals in Refractory Diffuse Large B-Cell Lymphoma Cells.

Inhibition of Phosphatidylinositol 3-Kinase Is Effective to Suppress the Growth of CD20-Negative Refractory Diffuse Large B-Cell Lymphoma Cells

Constitutive Cyclin A1 Expression Induces Abrogation of Cell Cycle Check Points Associated with Ara-C Resistance in Myeloid Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only